Skip to main content
Top

Cancer and Metastasis Reviews

Issue 4/2016

Breast Cancer Issue

Content (14 Articles)

Preface

Li Ma

Current challenges of metastatic breast cancer

Bora Lim, Gabriel N. Hortobagyi

PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment

Angel Guerrero-Zotano, Ingrid A. Mayer, Carlos L. Arteaga

Patient-derived xenograft (PDX) models in basic and translational breast cancer research

Lacey E. Dobrolecki, Susie D. Airhart, Denis G. Alferez, Samuel Aparicio, Fariba Behbod, Mohamed Bentires-Alj, Cathrin Brisken, Carol J. Bult, Shirong Cai, Robert B. Clarke, Heidi Dowst, Matthew J. Ellis, Eva Gonzalez-Suarez, Richard D. Iggo, Peter Kabos, Shunqiang Li, Geoffrey J. Lindeman, Elisabetta Marangoni, Aaron McCoy, Funda Meric-Bernstam, Helen Piwnica-Worms, Marie-France Poupon, Jorge Reis-Filho, Carol A. Sartorius, Valentina Scabia, George Sflomos, Yizheng Tu, François Vaillant, Jane E. Visvader, Alana Welm, Max S. Wicha, Michael T. Lewis

The role of deubiquitinases in breast cancer

Zhenna Xiao, Peijing Zhang, Li Ma

EMT, cell plasticity and metastasis

Christine L. Chaffer, Beatriz P. San Juan, Elgene Lim, Robert A. Weinberg

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine